An ancillary study of (a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer)-exploratory study of cost-effectiveness
Not Applicable
- Conditions
- on-small-cell lung cancer
- Registration Number
- JPRN-UMIN000042698
- Lead Sponsor
- Clinical Research Support Center Kyushu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing particular
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost-minimization analysis, cost- effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER), cost-utility ratio, incremental cost-utility ratio
- Secondary Outcome Measures
Name Time Method